Medindia LOGIN REGISTER
Medindia

Treatment can Benefit Patients With Both Thalassaemia and HCV

by Aishwarya Radhakrishnan on Jul 2 2017 4:23 PM

Treatment can Benefit Patients With Both Thalassaemia and HCV
Due to contaminated transfusions before 1990,many individuals with the blood disorder thalassaemia also carry the hepatitis C virus (HCV).
A new study indicates that treatment with a combination of sofosbuvir and ledipasvir as a once a day single pill leads to a sustained virological response in 98% of patients with thalassaemia and HCV.

"The findings are significant because, unlike other antiviral drugs, this simple treatment is expected not to be limited by drug-to-drug interactions with other medications usually taken by thalassaemia patients," said Dr. Alessandra Mangia, lead author of the Alimentary Pharmacology & Therapeutics study.



Source-Eurekalert


Advertisement